National Serology Reference Laboratory, Australia

Site

National Serology Reference Laboratory, Australia, a division of St. Vincent’s Institute

Accreditation No.

9534

Site No.

9527

Date of Accreditation

22 Apr 1997

Address

4th Floor, Healy Building, 41 Victoria Parade
Fitzroy, VIC 3065
Australia

nrlquality.org.au

Contact

Ms Lucy Waddell P: +61 0409181373

Availability

Services available to external clients

Supervision

Not Applicable

National Serology Reference Laboratory, Australia address map

Scope of Accreditation

Print scopes
National Serology Reference Laboratory, Australia, a division of St. Vincent’s Institute

ISO 15189 (2012)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses)Tests not used for diagnostic purposes Cadaveric donor plasma; Cadaveric donor serum Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA
Plasma; Serum Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation Plasma; Serum Syphilis Treponema pallidum antibody
Hepatitis C virus antibody (anti-HCV); Hepatitis C virus antigen (HCV Ag)
Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV) - IgG; Human T-lymphotropic virus type I/II (HTLV-I/II) antibody; Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody
Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies
Hepatitis C virus antibody (anti-HCV) - IgG; Human T-lymphotropic virus type I/II (HTLV-I/II) antibody; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies
Syphilis Treponema pallidum antibody

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.